MEDNAX’s Quantum Clinical Navigation System Certified by CMS as Qualified Clinical Data Registry

MEDNAX, Inc. (NYSE: MD) announced that its Quantum Clinical Navigation System®, a robust quality and outcomes data tool developed for its clinicians, has been certified by the Centers for Medicare and Medicaid Services (CMS) as a Qualified Clinical Data Registry (QCDR).

A QCDR is a new reporting mechanism available for the Physician Quality Reporting System (PQRS), the CMS program that uses a combination of incentive payments and payment adjustments to promote reporting of quality measures. CMS requires a very rigorous certification process to accept a quality data registry to be a QCDR.

“We are proud to be one of only a few anesthesiology QCDRs in the country to be designated as such by CMS,” said Katherine Grichnik, M.D., Director of Research, Education and Quality. “This certification provides a strong validation of the organizational commitment we’ve made to quality and outcomes data at MEDNAX.”

CMS qualified Quantum to report over thirty (30) performance metrics to be included in the QCDR.

The Quantum Clinical Navigation System was developed at Southeast Anesthesiology Consultants, which became part of MEDNAX in 2010.

More information can be found about Quantum on the Company’s website at www.mednax.com/why-mednax/health-it.

ABOUT MEDNAX

MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of neonatal, anesthesia, maternal-fetal and pediatric physician subspecialty services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a division of MEDNAX, was founded in 1979 and includes neonatal physicians who provide services at more than 370 neonatal intensive care units, and collaborate with affiliated maternal-fetal medicine, pediatric cardiology, pediatric critical care and other physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. American Anesthesiology, a division of MEDNAX, was established in 2007 and includes more than 2,400 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 2,675 physicians in 34 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to medical providers in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com.

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.